Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Daohong Zhou
Univ of Arkansas for Med Scis, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cenexys, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Zhou's interests with Cenexys, Inc. all relate to the development of senolytic drugs.
Discovery and Target Identification of Senolytic Agents
PROJECT NARRATIVE The proposed research uses piperlongumine, a natural dietary product isolated from a variety of Piper (pepper) species, as a lead candidate for developing novel senolytic agents, small molecules that can selectively kill senescent cells, and for identifying molecular targets that are important for survival of senescent cells. These studies, if successful, will lead to potential therapeutic agents for aging and age-related diseases.
Filed on October 12, 2017.
Tell us what you know about Daohong Zhou's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Daohong Zhou”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Daohong Zhou | Univ of Arkansas for Med Scis | Conflict of Interest | Cenexys, Inc. | $40,000 - $59,999 |
| Daohong Zhou | Univ of Arkansas for Med Scis | Conflict of Interest | Cenexys, Inc. | $40,000 - $59,999 |
| Daohong Zhou | University of Florida | Conflict of Interest | Dialectic Therapeutics, Inc. | Value cannot be readily determined |
| Daohong Zhou | Univ of Arkansas for Med Scis | Conflict of Interest | Cenexys, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.